| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |